Beyang Therapeutics
AI-driven drug discovery company using its ExCEED molecular design platform
$30MSeries A
Role not disclosedSH
Shanghai Healthcare Capital
Activity from announced rounds
Activity in this selectionlinda-tong-431a93fe
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $30M 1 disclosed · full round size, not this investor’s share